Pratosartan

DB20100ExperimentalSmall molecule

Pratosartan is a small molecule drug. The usage of the INN stem '-sartan' in the name indicates that Pratosartan is a angiotensin II receptor antagonist, antihypertensive (non-peptidic). Pratosartan has a... Pratosartan has a monoisotopic molecular weight of 426.22 Da.

Mechanism: Pharmacologically active on Type-1 angiotensin II receptor, Solute carrier family 22 member 6, and Organic anion transporter 3
Curator reviewed
Formula / weight: C₂₅H₂₆N₆O · 426.524 g/mol (avg)
Code names: DA-727 · KT3-671

Resolves to

Compound

UNII66VLQ6E6DLCAS153804-05-8ChEMBLCHEMBL41194ChEBI32041PubChem9802561

Structure

InChIKeyKCTFTBCZZUBAKN-UHFFFAOYSA-NSMILESCCCC1=NC2=C(N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1)C(=O)CCCC2

Targets

P30556AGTR1Q4U2R8SLC22A6Q8TCC7SLC22A8Q96S37SLC22A12

What you can answer from here — as of September 23, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

8+ReferencesStructured and connected to the statements they support

Which drugs share a target with Pratosartan, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account